PROM1 and glioma: On the other hand, as observed in glioma, CSCs (CD133-positive cells) are able to repair DNA damage more efficiently and rapidly than CD133 negative cells and this might decrease the tumor mutational load and, by consequence, tumor immunogenicity 24.